Interestingly, biased PAR2 antagonists that selectively block certain signaling pathways, attenuate MC degranulation and collagen-induced arthritis in rats [60], activate ERK1/2 in rat kidney epithelial cells [37], and suppresses inflammation and itch in mouse models of AD [61]. This evidence concerns the gene MAPK3 and arthritic joint disease.